These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 23582471)
1. Microtools for single-cell analysis in biopharmaceutical development and manufacturing. Love KR; Bagh S; Choi J; Love JC Trends Biotechnol; 2013 May; 31(5):280-6. PubMed ID: 23582471 [TBL] [Abstract][Full Text] [Related]
2. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins. van Beers MM; Bardor M Biotechnol J; 2012 Dec; 7(12):1473-84. PubMed ID: 23027660 [TBL] [Abstract][Full Text] [Related]
3. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
4. Market access for biopharmaceuticals: new challenges. Simon F Health Aff (Millwood); 2006; 25(5):1363-70. PubMed ID: 16966734 [TBL] [Abstract][Full Text] [Related]
5. A new large-scale manufacturing platform for complex biopharmaceuticals. Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835 [TBL] [Abstract][Full Text] [Related]
11. Conference scene: recent advancements in microscale bioprocess development. Guy H Immunotherapy; 2012 Feb; 4(2):145-7. PubMed ID: 22339457 [TBL] [Abstract][Full Text] [Related]
12. A special report on India's biotech scenario: advancement in biopharmaceutical and health care sectors. Chakraborty C; Agoramoorthy G Biotechnol Adv; 2010; 28(1):1-6. PubMed ID: 19931371 [TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography. Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320 [TBL] [Abstract][Full Text] [Related]
15. Medium term planning of biopharmaceutical manufacture using mathematical programming. Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554 [TBL] [Abstract][Full Text] [Related]
16. Early implementation of QbD in biopharmaceutical development: a practical example. Zurdo J; Arnell A; Obrezanova O; Smith N; Gómez de la Cuesta R; Gallagher TR; Michael R; Stallwood Y; Ekblad C; Abrahmsén L; Höidén-Guthenberg I Biomed Res Int; 2015; 2015():605427. PubMed ID: 26075248 [TBL] [Abstract][Full Text] [Related]